PAN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.353200E-01
Normal-vs-Stage2
3.752200E-01
Normal-vs-Stage3
2.410400E-01
Normal-vs-Stage4
2.657600E-01
Stage1-vs-Stage2
5.008600E-01
Stage1-vs-Stage3
7.120100E-03
Stage1-vs-Stage4
5.756400E-01
Stage2-vs-Stage3
6.334500E-02
Stage2-vs-Stage4
9.034800E-01
Stage3-vs-Stage4
9.369800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.699200E-01
Normal-vs-AfricanAmerican
3.399600E-01
Normal-vs-Asian
3.436400E-01
Caucasian-vs-AfricanAmerican
6.299600E-01
Caucasian-vs-Asian
5.815400E-01
AfricanAmerican-vs-Asian
9.532400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.716400E-01
Normal-vs-Female
3.657400E-01
Male-vs-Female
8.342400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.644200E-01
Normal-vs-Age(41-60Yrs)
4.008400E-01
Normal-vs-Age(61-80Yrs)
3.538400E-01
Normal-vs-Age(81-100Yrs)
3.471200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.334400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.037200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.902550E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.525610E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.252000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.497600E-01
Normal-vs-Daily Drinker
3.571200E-01
Normal-vs-Weekly Drinker
3.242800E-01
Normal-vs-Occasional Drinker
3.999200E-01
Normal-vs-Social Drinker
3.866000E-01
Non Drinker-vs-Daily Drinker
8.916000E-01
Non Drinker-vs-Weekly Drinker
6.079600E-01
Non Drinker-vs-Occasional Drinker
3.958000E-01
Non Drinker-vs-Social Drinker
5.288600E-01
Daily Drinker-vs-Weekly Drinker
5.625200E-01
Daily Drinker-vs-Occasional Drinker
4.954200E-01
Daily Drinker-vs-Social Drinker
6.288200E-01
Weekly Drinker-vs-Occasional Drinker
2.880800E-01
Weekly Drinker-vs-Social Drinker
3.635800E-01
Occasional Drinker-vs-Social Drinker
8.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.885700E-02
Normal-vs-Grade 2
4.571400E-04
Normal-vs-Grade 3
8.826100E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.723800E-01
Grade 1-vs-Grade 3
6.305800E-01
Grade 1-vs-Grade 4
2.885700E-02
Grade 2-vs-Grade 3
5.610400E-01
Grade 2-vs-Grade 4
4.571400E-04
Grade 3-vs-Grade 4
8.826100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.400800E-01
Normal-vs-NonDiabetic
3.697800E-01
Diabetic-vs-NonDiabetic
3.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.413600E-01
Normal-vs-NoPancreatitis
3.606600E-01
Pancreatitis-vs-NoPancreatitis
6.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.569200E-01
Normal-vs-N1
3.735800E-01
N0-vs-N1
5.734200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.142400E-01
Normal-vs-TP53-NonMutant
4.094000E-01
TP53-Mutant-vs-TP53-NonMutant
9.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
